Dyne Therapeutics DYN
NASDAQ DYN
$15.20 -0.62 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Dyne Therapeutics (DYN) posted Return on Capital Employed [ROCE] of -55.99% for Q2 2026, up 8.50 percentage points from -64.49% a year earlier but down 12.46 percentage points from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Dyne Therapeutics' Return on Capital Employed [ROCE] came in at -52.70%, up 36.42 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -18.97 percentage points (FY2020 to FY2025).
  • In prior years, Dyne Therapeutics' Return on Capital Employed [ROCE] was -89.11% in FY2024 (+42.06 pp), -131.18% in FY2023 (-80.58 pp), -50.59% in FY2022 (-9.01 pp) and -41.58% in FY2021 (-7.86 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -180.63% in Q4 2023 to a high of -28.55% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of +25.64 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 130.64 percentage points; the weakest was Q4 2023, with a drop of 118.44 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -43.53% (Q1 2026), -47.95% (Q4 2025) and -60.85% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 17.83%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 17.92%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.28%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 19.32%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.54%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 16.66%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -5.97%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.76%
10 Dyne Therapeutics 2.67 Bn 2.67 Bn - -55.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.99%
Mar 31, 2026 -43.53%
Dec 31, 2025 -47.95%
Sep 30, 2025 -60.85%
Jun 30, 2025 -64.49%
Mar 31, 2025 -59.06%
Dec 31, 2024 -49.99%
Sep 30, 2024 -41.69%
Jun 30, 2024 -42.07%
Mar 31, 2024 -82.74%
Dec 31, 2023 -180.63%
Sep 30, 2023 -108.04%
Jun 30, 2023 -77.91%
Mar 31, 2023 -65.47%
Dec 31, 2022 -62.19%
Sep 30, 2022 -61.64%
Jun 30, 2022 -54.18%
Mar 31, 2022 -41.90%
Dec 31, 2021 -35.93%
Sep 30, 2021 -28.55%
API Access

Dyne Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DYN&period=max&api_key=YOUR_API_KEY